BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind ...
FDA Recall #D-0549-2023 — Class II — March 16, 2023
Product Description
BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-511-52
Reason for Recall
CGMP Deviations
Recalling Firm
Northwind Pharmaceuticals LLC — Indianapolis, IN
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
6 bottles
Distribution
Nationwide with the United States
Code Information
Lot#: F117312201, Exp. Date 06/30/2024
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated